Department of Pharmacology, Faculty of Pharmacy, Mersin University, Mersin, Turkey.
Drug Dev Res. 2021 Sep;82(6):815-825. doi: 10.1002/ddr.21786. Epub 2021 Feb 8.
Epoxyeicosatrienoic acids (EETs) have anti-inflammatory effects and soluble epoxide hydrolase (sEH) inhibition might be a useful therapeutic approach to manage inflammatory disorders. The purpose of the study was to investigate whether nucleotide-binding and oligomerization domain-like receptor (NLR) C4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the central nervous system (CNS) participates in the effect of trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea (TPPU), a potent sEH inhibitor, to prevent hyperalgesia in the LPS-induced pain mouse model. The latency of pain within 30 s was measured by the hot plate test in male mice injected with saline, lipopolysaccharide (LPS) (10 mg/kg), and/or TPPU (0.3, 0.5, or 1 mg/kg) after 6 h. Hyperalgesia induced by LPS was associated with decreased 14,15-dihydroxyeicosatrienoic acid and interleukin (IL)-1β levels and enhanced expression of NLRC4, apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), caspase-1 p20, IL-1β, and caspase-11 p20 in the brains and spinal cords of the animals. Besides the increased expression of nicotinamide adenine dinucleotide phosphate oxidase (NOX) subunits (gp91 and p47 ) and nitrotyrosine, a decrease in NLRC3, inducible nitric oxide synthase (iNOS), and neuronal NOS (nNOS) expression was also observed in the tissues of LPS-treated mice. TPPU at 0.5 mg/kg dose prevented the changes induced by LPS. Likely, decreased activity of pro-inflammatory NLRC4/ASC/pro-caspase-1 and caspase-11 inflammasomes and NOX in addition to enhanced levels of anti-inflammatory EETs and expression of NLRC3, iNOS, and nNOS in the CNS of mice participates in the protective effect of TPPU against LPS-induced hyperalgesia.
环氧二十碳三烯酸(EETs)具有抗炎作用,而可溶性环氧化物水解酶(sEH)抑制可能是治疗炎症性疾病的一种有效方法。本研究旨在探讨核苷酸结合寡聚化结构域样受体(NLR)C4 炎性体相关的促炎和抗炎信号通路在中枢神经系统(CNS)中是否参与了强效 sEH 抑制剂三氟甲氧基苯基-3-(1-丙酰基哌啶-4-基)脲(TPPU)预防脂多糖(LPS)诱导的疼痛小鼠模型中痛觉过敏的作用。雄性小鼠在注射生理盐水、脂多糖(LPS)(10mg/kg)和/或 TPPU(0.3、0.5 或 1mg/kg)6 小时后,通过热板试验测量 30 秒内的疼痛潜伏期。LPS 诱导的痛觉过敏与脑和脊髓中 14,15-二羟基二十碳三烯酸和白细胞介素(IL)-1β水平降低以及 NLRC4、凋亡相关斑点样蛋白包含半胱氨酸蛋白酶激活和募集结构域(ASC)、半胱天冬酶-1 p20、IL-1β和半胱天冬酶-11 p20 的表达增强有关。除了烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX)亚基(gp91 和 p47)和硝基酪氨酸表达增加外,还观察到 LPS 处理小鼠组织中 NLRC3、诱导型一氧化氮合酶(iNOS)和神经元型一氧化氮合酶(nNOS)表达减少。TPPU 以 0.5mg/kg 剂量可预防 LPS 引起的变化。可能的是,CNS 中促炎 NLRC4/ASC/前半胱天冬酶-1 和半胱天冬酶-11 炎性体活性降低以及 EETs 水平升高和 NLRC3、iNOS 和 nNOS 表达增强参与了 TPPU 对 LPS 诱导的痛觉过敏的保护作用。